Colombo Antonio, Ruparelia Neil
San Raffaele Scientific Institute, Milan, Italy.
EuroIntervention. 2015 Sep;11 Suppl W:W20-2. doi: 10.4244/EIJV11SWA5.
Historically, the only interventional management option for valve pathology was cardiac surgery. However, the rapid evolution of transcatheter valve interventions has catapulted cardiologists into a central role in the management of these patients. A welcome consequence of this rapid change in the landscape has been the fostering of new and improved relationships between cardiologists and cardiac surgeons and the formulation of "Heart Teams" to facilitate patient management. We believe that the cardiologist, who already utilises many of the clinical and procedural skills required to manage this complex group of patients, is optimally placed to be the central figure within the multidisciplinary team, and to deliver these treatments with the ultimate aim of achieving the best possible patient outcomes.
从历史上看,对于瓣膜病变,唯一的介入治疗选择是心脏手术。然而,经导管瓣膜介入技术的迅速发展已使心脏病专家在这些患者的管理中发挥核心作用。这种格局的快速变化带来的一个可喜结果是,心脏病专家与心脏外科医生之间建立了新的、更好的关系,并组建了“心脏团队”以促进患者管理。我们认为,心脏病专家已经具备管理这类复杂患者所需的许多临床和操作技能,最适合成为多学科团队的核心人物,并开展这些治疗,最终目标是实现最佳的患者治疗效果。